Sign In
Buy PACB
$1.15
-0.0350 (-2.95%)
At Close: Aug 10, 2026
Pacific Biosciences of California (PACB) Suffers a Larger Drop Than the General Market: Key Insights
07:16pm, Tuesday, 29'th Jul 2025
Pacific Biosciences of California (PACB) reached $1.54 at the closing of the latest trading day, reflecting a -6.1% change compared to its last close.
Athena Diagnostics Improves Ataxia Movement Disorder Testing with Novel Long-Read Gene Sequencing
08:52am, Tuesday, 29'th Jul 2025
New test utilizes technology based on PacBio's PureTarget sequencing method to uncover genetic causes of disease BOSTON , July 29, 2025 /PRNewswire/ -- Athena Diagnostics, the specialty neurology bus
PacBio HiFi Sequencing Powers First Arab Human Pangenome, Published in Nature Communications
09:05am, Thursday, 24'th Jul 2025
Study reveals millions of previously unknown variants and genomic sequences from underrepresented populations Study reveals millions of previously unknown variants and genomic sequences from underrepr
PacBio Joins the 1000 Genomes Long Read Project to Add Isoform Sequencing with Kinnex and Revio
09:05am, Wednesday, 23'rd Jul 2025
New Iso-Seq data from ~1,000 samples to expand transcriptomic insights using highly accurate HiFi sequencing New Iso-Seq data from ~1,000 samples to expand transcriptomic insights using highly accurat
PacBio to Report Second Quarter 2025 Financial Results on August 7, 2025
04:05pm, Monday, 21'st Jul 2025
MENLO PARK, Calif., July 21, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its second quarter 2025 financial results on Thur
Pacific Biosciences of California (PACB) Beats Stock Market Upswing: What Investors Need to Know
07:16pm, Thursday, 10'th Jul 2025
The latest trading day saw Pacific Biosciences of California (PACB) settling at $1.5, representing a +1.35% change from its previous close.
Here's Why You Should Add PacBio Stock to Your Portfolio Now
01:01pm, Wednesday, 09'th Jul 2025
PACB benefits from strong first-quarter results, product innovation, and cost cuts to offset macroeconomic concerns and drive 2025 growth.
Pacific Biosciences (PACB) Upgraded to Strong Buy: Here's What You Should Know
01:00pm, Tuesday, 08'th Jul 2025
Pacific Biosciences (PACB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Pacific Biosciences of California (PACB) Outperforms Broader Market: What You Need to Know
07:16pm, Thursday, 12'th Jun 2025
Pacific Biosciences of California (PACB) closed at $1.18 in the latest trading session, marking a +1.72% move from the prior day.
Here's Why You Should Add PacBio Stock to Your Portfolio Now
01:11pm, Thursday, 05'th Jun 2025
PACB benefits from strong first-quarter results, product innovation, and cost cuts to offset sales cycle delays and drive 2025 growth.
Target ALS Chooses PacBio HiFi Sequencing to Advance ALS Research with Largest Global Genomic Study to Date
10:00am, Monday, 02'nd Jun 2025
Organization's 6,000-genome effort will power global ALS research through detailed long-read sequencing data made freely available to scientists worldwide NEW YORK and MENLO PARK, Calif. , June 2, 202
All You Need to Know About Pacific Biosciences (PACB) Rating Upgrade to Buy
01:06pm, Thursday, 29'th May 2025
Pacific Biosciences (PACB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
PacBio Stock Slips Despite New China Distribution Deal With Haorui
11:51am, Friday, 23'rd May 2025
PACB expands reach in China through Haorui Gene partnership, bringing HiFi sequencing to new clinical labs and boosting precision medicine access nationwide.
PACB Stock May Rise Following the Deal With Chulalongkorn University
02:05pm, Monday, 12'th May 2025
PacBio and Chulalongkorn University launch Asia Pacific's first population-scale HiFi WGS newborn screening program, advancing precision medicine in Thailand.
PacBio Board Independent Investigation Concludes Allegations Unsubstantiated
10:56am, Monday, 12'th May 2025
MENLO PARK, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced that the Special Committee of its Board of Directors (the “Special Committee”) has concluded its independ
